Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 47: 128206, 2021 09 01.
Article in English | MEDLINE | ID: mdl-34146704

ABSTRACT

Acetylcholinesterase (AChEis) inhibitors are used to treat neurodegenerative diseases like Alzheimer's disease (AD). l-Hypaphorine (l-HYP) is a natural indole alkaloid that has been shown to have effects on the central nervous system (CNS). The goal of this research was to synthesize l-HYP and d-HYP and test their anticholinesterasic properties in rat brain regions. l-HYP suppressed acetylcholinesterase (AChE) activity only in the cerebellum, whereas d-HYP inhibited AChE activity in all CNS regions studied. No cytotoxic effect on normal human cells (HaCaT) was observed in the case of l-HYP and d-HYP although an increase in cell proliferation. Molecular modeling studies revealed that d-HYP and l-HYP have significant differences in their binding mode positions and interact stereospecifically with AChE's amino acid residues.


Subject(s)
Acetylcholinesterase/metabolism , Brain/enzymology , Cholinesterase Inhibitors/pharmacology , Indoles/pharmacology , Animals , Brain/pathology , Cholinesterase Inhibitors/chemistry , Dose-Response Relationship, Drug , Indoles/chemistry , Molecular Structure , Rats , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...